BKBG
XLRN

BHF Kleinwort Benson Group’s Acceleron Pharma XLRN Stock Holding History

BHF Kleinwort Benson Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,930
Closed -$334K – 529
2015
Q2 		$334K Buy
+10,930
New +$353K 0.01% 354

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BHF Kleinwort Benson Group's XLRN Position: Q3 2015 in Review

BHF Kleinwort Benson Group sold out of Acceleron Pharma (XLRN) in Q3 2015, closing a stake of 10,930 shares — an estimated $334K sold.

BHF Kleinwort Benson Group first reported a position in XLRN in Q2 2015 and held it in 1 quarter. The position peaked at $334K in Q2 2015. 111 funds tracked by Wall St. Rank hold XLRN as of Q3 2015.

  • BHF Kleinwort Benson Group reported no remaining Acceleron Pharma position as of Q3 2015 after selling out during the quarter.
  • BHF Kleinwort Benson Group sold 10,930 Acceleron Pharma shares in Q3 2015, an estimated $334K.
  • BHF Kleinwort Benson Group first reported a position in Acceleron Pharma in Q2 2015 and held it in 1 quarter.
  • BHF Kleinwort Benson Group's Acceleron Pharma position peaked at $334K in Q2 2015.
  • 111 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2015.

Based on BHF Kleinwort Benson Group's 13F filing for Q3 2015, filed 13 Nov 2015.